U S Physical Therapy Capital Expenditures (CapEx) Growth & History (USPH)
U S Physical Therapy's capital expenditures (capex) was $14.1M for fiscal 2025.
View full U S Physical Therapy company overviewU S Physical Therapy annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.1M | $4.9M | +53.18% |
| 2024 | 2024-12-31 | $9.2M | −$108,000 | −1.16% |
| 2023 | 2023-12-31 | $9.3M | $1.0M | +12.68% |
| 2022 | 2022-12-31 | $8.2M | $47,000 | +0.57% |
| 2021 | 2021-12-31 | $8.2M | $562,000 | +7.36% |
| 2020 | 2020-12-31 | $7.6M | −$2.5M | −25.03% |
| 2019 | 2019-12-31 | $10.2M | $3.0M | +41.65% |
| 2018 | 2018-12-31 | $7.2M | $98,000 | +1.38% |
| 2017 | 2017-12-31 | $7.1M | −$1.2M | −14.10% |
| 2016 | 2016-12-31 | $8.3M | $2.0M | +31.89% |
| 2015 | 2015-12-31 | $6.3M | $1.1M | +21.21% |
| 2014 | 2014-12-31 | $5.2M | $530,000 | +11.43% |
| 2013 | 2013-12-31 | $4.6M | $403,000 | +9.52% |
| 2012 | 2012-12-31 | $4.2M | $1.0M | +31.41% |
| 2011 | 2011-12-31 | $3.2M | −$451,000 | −12.28% |
| 2010 | 2010-12-31 | $3.7M | −$203,000 | −5.24% |
| 2009 | 2009-12-31 | $3.9M | — | — |
U S Physical Therapy quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.4M | $2.1M | +65.00% |
| Q1 2026 | 2026-03-31 | $5.4M | $2.8M | +108.34% |
| Q4 2025 | 2025-12-31 | $3.9M | $1.4M | +57.73% |
| Q3 2025 | 2025-09-30 | $4.3M | $1.8M | +71.03% |
| Q2 2025 | 2025-06-30 | $3.3M | $915,000 | +39.17% |
| Q1 2025 | 2025-03-31 | $2.6M | $741,000 | +40.32% |
| Q4 2024 | 2024-12-31 | $2.5M | $269,000 | +12.12% |
| Q3 2024 | 2024-09-30 | $2.5M | −$28,000 | −1.10% |
| Q2 2024 | 2024-06-30 | $2.3M | −$128,000 | −5.19% |
| Q1 2024 | 2024-03-31 | $1.8M | −$221,000 | −10.73% |
| Q4 2023 | 2023-12-31 | $2.2M | $1.3M | +131.73% |
| Q3 2023 | 2023-09-30 | $2.6M | −$170,000 | −6.25% |
| Q2 2023 | 2023-06-30 | $2.5M | $423,000 | +20.73% |
| Q1 2023 | 2023-03-31 | $2.1M | −$469,000 | −18.55% |
| Q4 2022 | 2022-12-31 | $958,000 | −$1.2M | −56.55% |
| Q3 2022 | 2022-09-30 | $2.7M | $26,000 | +0.96% |
| Q2 2022 | 2022-06-30 | $2.0M | $348,000 | +20.56% |
| Q1 2022 | 2022-03-31 | $2.5M | $920,000 | +57.21% |
| Q4 2021 | 2021-12-31 | $2.2M | $60,000 | +2.80% |
| Q3 2021 | 2021-09-30 | $2.7M | $1.8M | +211.20% |
| Q2 2021 | 2021-06-30 | $1.7M | −$181,000 | −9.66% |
| Q1 2021 | 2021-03-31 | $1.6M | −$1.1M | −41.61% |
| Q4 2020 | 2020-12-31 | $2.1M | −$616,000 | −22.31% |
| Q3 2020 | 2020-09-30 | $866,000 | −$1.7M | −66.07% |
| Q2 2020 | 2020-06-30 | $1.9M | −$505,000 | −21.23% |
| Q1 2020 | 2020-03-31 | $2.8M | $257,000 | +10.29% |
| Q4 2019 | 2019-12-31 | $2.8M | $875,000 | +46.39% |
| Q3 2019 | 2019-09-30 | $2.6M | $515,000 | +25.28% |
| Q2 2019 | 2019-06-30 | $2.4M | $513,000 | +27.49% |
| Q1 2019 | 2019-03-31 | $2.5M | $1.1M | +77.85% |
| Q4 2018 | 2018-12-31 | $1.9M | $367,000 | +24.16% |
| Q3 2018 | 2018-09-30 | $2.0M | −$294,000 | −12.61% |
| Q2 2018 | 2018-06-30 | $1.9M | $208,000 | +12.55% |
| Q1 2018 | 2018-03-31 | $1.4M | −$183,000 | −11.53% |
| Q4 2017 | 2017-12-31 | $1.5M | −$1.1M | −42.46% |
| Q3 2017 | 2017-09-30 | $2.3M | $164,000 | +7.57% |
| Q2 2017 | 2017-06-30 | $1.7M | −$57,000 | −3.32% |
| Q1 2017 | 2017-03-31 | $1.6M | −$151,000 | −8.69% |
| Q4 2016 | 2016-12-31 | $2.6M | $1.1M | +67.83% |
| Q3 2016 | 2016-09-30 | $2.2M | $350,000 | +19.26% |
| Q2 2016 | 2016-06-30 | $1.7M | $261,000 | +17.95% |
| Q1 2016 | 2016-03-31 | $1.7M | $319,000 | +22.48% |
| Q4 2015 | 2015-12-31 | $1.6M | $318,000 | +25.34% |
| Q3 2015 | 2015-09-30 | $1.8M | $37,000 | +2.08% |
| Q2 2015 | 2015-06-30 | $1.5M | $171,000 | +13.33% |
| Q1 2015 | 2015-03-31 | $1.4M | $570,000 | +67.14% |
| Q4 2014 | 2014-12-31 | $1.3M | $76,000 | +6.45% |
| Q3 2014 | 2014-09-30 | $1.8M | $716,000 | +67.29% |
| Q2 2014 | 2014-06-30 | $1.3M | $159,000 | +14.15% |
| Q1 2014 | 2014-03-31 | $849,000 | −$421,000 | −33.15% |
| Q4 2013 | 2013-12-31 | $1.2M | −$107,000 | −8.32% |
| Q3 2013 | 2013-09-30 | $1.1M | $59,000 | +5.87% |
| Q2 2013 | 2013-06-30 | $1.1M | $77,000 | +7.35% |
| Q1 2013 | 2013-03-31 | $1.3M | $374,000 | +41.74% |
| Q4 2012 | 2012-12-31 | $1.3M | $492,000 | +61.96% |
| Q3 2012 | 2012-09-30 | $1.0M | $61,000 | +6.46% |
| Q2 2012 | 2012-06-30 | $1.0M | $423,000 | +67.79% |
| Q1 2012 | 2012-03-31 | $896,000 | $36,000 | +4.19% |
| Q4 2011 | 2011-12-31 | $794,000 | — | — |
| Q3 2011 | 2011-09-30 | $944,000 | −$138,000 | −12.75% |
| Q2 2011 | 2011-06-30 | $624,000 | — | — |
| Q1 2011 | 2011-03-31 | $860,000 | — | — |
| Q3 2010 | 2010-09-30 | $1.1M | — | — |
U S Physical Therapy capital expenditures (capex) trends
Over the last five fiscal years, U S Physical Therapy's capital expenditures (capex) increased from $7.6M to $14.1M, a change of $6.4M. The latest reported quarter, Q2 2026, shows $5.4M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review U S Physical Therapy source filings ↗